Find your next paid study

K. Kay Durairaj, MD, FACS, A Medical CorporationNCT07810504

~$10 – $8,750

Colorectal Cancer (Diagnosis)Anal CancerSexual Dysfunction Female

Refining a Mind-Body Sexual Well-Being Program for Female GI Cancer Survivors

This record describes two distinct study phases: 1) A small open pilot trial including up to 10 participants, intended to generate descriptive feedback on rega…

Massachusetts General HospitalNCT07795801

Natural History Study of Patients With Excess Androgen

This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effe…

Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00250159

~$10 – $675

Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)FemaleAdult+9 more

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Female Adults With Prediabetes.

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, …

Georgia State UniversityNCT06735651

Hypertension (Without Type 2 Diabetes Mellitus)High Blood PressureMale+13 more

Effects of Wild Blueberry Consumption on Gut, Brain, and Cardiovascular Health in Non-Hispanic Black and White Adults With High Blood Pressure

The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in …

Georgia State UniversityNCT06735599

Phase 2

ETHAN: A Phase II Study Comparing Different Endocrine THerapies for mAle Breast caNcer

This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen…

Male Breast CancerHormone Receptor-positive Breast CancerHormone Receptor Negative Breast Carcinoma

Jose Pablo LeoneNCT05501704

~$10 – $7,500

Healthy Adult FemalesHealthy Adult Males

Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Corn

The purpose of this research study is to identify biomarkers of whole grain (WG) corn intake following an acute exposure in a pharmacokinetic (how the body abs…

North Carolina Agriculture & Technical State UniversityNCT07767162

Phase 1

A Phase 1 Study to Evaluate the Mass Balance, Metabolism, Excretion, and Pharmacokinetics of [14C]Navlimetostat (BMS-986504) at Steady State in Healthy Female Participants

The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of \[14C\]Navlimetostat (BMS-986504) in healthy …

Healthy Female Participants

Bristol-Myers SquibbNCT07777133

~$10 – $7,500

Polycystic Ovarian Syndrome in Adolescent FemalesVitamin D Deficiency

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

This study is a double blind, placebo controlled, randomized trial of study subjects with PCOS and low vitamin D to 2 groups- placebo and vitamin D replacement…

Yale UniversityNCT04355572

Breast CancerBreast NeoplasmsBreast Cancer Female+1 more

Outcome of Biennial Screening Contrast-Enhanced Mammography (CEM) in Women With a Personal History of Breast Cancer (PHBC)

This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially i…

Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more

~$10 – $7,500

Wendie BergNCT06105749

Phase 1

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent and in co…

Marengo Therapeutics, Inc.NCT05592626

~$10 – $8,750

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more

An e-Health Intervention for Fear of Progression in Women With Gynecologic or Breast Cancer

This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women…